BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24739713)

  • 21. Oral manifestations of smokeless tobacco use.
    Greer RO
    Otolaryngol Clin North Am; 2011 Feb; 44(1):31-56, v. PubMed ID: 21093622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco use and oral disease.
    Winn DM
    J Dent Educ; 2001 Apr; 65(4):306-12. PubMed ID: 11336115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral mucosal findings associated with chewing tobacco in Sweden--a clinical and histological study.
    Axéll T; Andersson G; Larsson A
    J Dent Assoc S Afr; 1992 May; 47(5):194-6. PubMed ID: 1401416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toombak-associated oral mucosal lesions in Sudanese show a low prevalence of epithelial dysplasia.
    Idris AM; Warnakulasuriya KA; Ibrahim YE; Nielsen R; Cooper D; Johnson NW
    J Oral Pathol Med; 1996 May; 25(5):239-44. PubMed ID: 8835821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of smokeless tobacco use in athletes.
    Guggenheimer J
    Dent Clin North Am; 1991 Oct; 35(4):797-808. PubMed ID: 1936412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hand eczema and use of snus (moist snuff) - a population-based study.
    Wrangsjö K; Alderling M; Lindahl G; Meding B
    Acta Derm Venereol; 2015 Mar; 95(3):298-302. PubMed ID: 24854399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tobacco, snuff and oral health].
    Heikkinen AM; Meurman JH; Sorsa T
    Duodecim; 2015; 131(21):1975-80. PubMed ID: 26677547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts.
    Arefalk G; Hergens MP; Ingelsson E; Arnlöv J; Michaëlsson K; Lind L; Ye W; Nyrén O; Lambe M; Sundström J
    Eur J Prev Cardiol; 2012 Oct; 19(5):1120-7. PubMed ID: 21828223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a 72-hour repeated exposure to Swedish snus extract and total particulate matter from 3R4F cigarette smoke on gingival organotypic cultures.
    Zanetti F; Sewer A; Titz B; Schlage WK; Iskandar AR; Kondylis A; Leroy P; Guedj E; Trivedi K; Elamin A; Martin F; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
    Food Chem Toxicol; 2019 Mar; 125():252-270. PubMed ID: 30610935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smokeless tobacco extracts activate complement in vitro: a potential pathogenic mechanism for initiating inflammation of the oral mucosa.
    Chang T; Chowdhry S; Budhu P; Kew RR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):223-9. PubMed ID: 9646831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral mucosal smokeless tobacco lesions among adolescents in the United States.
    Tomar SL; Winn DM; Swango PA; Giovino GA; Kleinman DV
    J Dent Res; 1997 Jun; 76(6):1277-86. PubMed ID: 9168861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of micronuclei in oral mucosa of users of tobacco products singly or in various combinations.
    Kayal JJ; Trivedi AH; Dave BJ; Nair J; Nair UJ; Bhide SV; Goswami UC; Adhvaryu SG
    Mutagenesis; 1993 Jan; 8(1):31-3. PubMed ID: 8450765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice.
    Stenström B; Zhao CM; Rogers AB; Nilsson HO; Sturegård E; Lundgren S; Fox JG; Wang TC; Wadström TM; Chen D
    Carcinogenesis; 2007 Sep; 28(9):2041-6. PubMed ID: 17389611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health risks related to dual use of cigarettes and snus - a systematic review.
    Lee PN
    Regul Toxicol Pharmacol; 2014 Jun; 69(1):125-34. PubMed ID: 24184647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathology of smokeless tobacco lesions in professional baseball players. Associations with different types of tobacco.
    Daniels TE; Hansen LS; Greenspan JS; Grady DG; Hauck WW; Greene JC; Ernster VL
    Oral Surg Oral Med Oral Pathol; 1992 Jun; 73(6):720-5. PubMed ID: 1279496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of keratin 13, 14 and 19 in oral hyperplastic and dysplastic lesions from Sudanese and Swedish snuff-dippers: association with human papillomavirus infection.
    Ibrahim SO; Warnakulasuriya KA; Idris AM; Hirsch JM; Johnson NW; Johannessen AC
    Anticancer Res; 1998; 18(1B):635-45. PubMed ID: 9584046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco Use, Oral Health, and Risk of Parkinson's Disease.
    Liu Z; Roosaar A; Axéll T; Ye W
    Am J Epidemiol; 2017 Apr; 185(7):538-545. PubMed ID: 28338925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral effects of smokeless tobacco use by professional baseball players.
    Robertson PB; Walsh MM; Greene JC
    Adv Dent Res; 1997 Sep; 11(3):307-12. PubMed ID: 9524430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversibility of snuff dippers' lesion in Swedish moist snuff users: a clinical and histologic follow-up study.
    Larsson A; Axéll T; Andersson G
    J Oral Pathol Med; 1991 Jul; 20(6):258-64. PubMed ID: 1890661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.